Search for: "David Lilly" Results 141 - 160 of 256
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
23 Mar 2012, 7:31 am by Joshua Matz
  At The Hill, Mike Lillis reports on Nancy Pelosi’s characterization of the Affordable Care Act as “iron-clad constitutionally. [read post]
12 Mar 2012, 8:13 am by Ronald Collins
Lincoln & the Negroes: The Long Road to Equality  (1963) William Rehnquist, Civil Liberty and the Civil War (1997) Similarly, some of the Justices were keenly interested and wrote works on religion and related topics: David J. [read post]
9 Mar 2012, 1:12 pm by Pilar G. Kraman
Other speakers include: • David Kappos, undersecretary of commerce for intellectual property and director, USPTO • Judge Paul Michel • Gary Griswold, president and chief intellectual property counsel, 3M Innovative Properties Company and former chairman, 21st Century Patent Reform • Bob Stoll, former commissioner, USPTO and partner, Drinker Biddle & Reath • Robert Armitage, senior VP and general counsel, Eli Lilly • Steven Wood, patent… [read post]
16 Feb 2012, 11:55 pm
The Public Voice  conference, chaired by Lillie Coney of EPIC, had as its theme: “Privacy is Freedom” One of the highlights was a discussion between David Benasar, Senior Legal Counsel Aticle 19 and Marc Rotenberg, President of EPIC, titled: Frame [...] [read post]
5 Feb 2012, 5:01 pm by Lawrence Higgins
Eli Lilly's profit dropped 27% because of Zyprexa going generic. [read post]
20 Nov 2011, 9:39 pm
David's presence should help give PatLit the sort of credibility as a patent litigation weblog which requires a first-hand, first-rate American to be in the team. [read post]
16 Jul 2011, 8:42 am
Wilburn was taken to Methodist Hospitals Northlake campus in Gary where she was pronounced dead, according to Simon Lillie, a public relations officer for the Gary Police Department. [read post]
23 Jun 2011, 6:33 pm by Frank Pasquale
David Orentlicher notes, “For $98 a year . . . physicians can subscribe to The Medical Letter on Drugs and Therapeutics, a respected and independent, biweekly newsletter that provides evaluations of prescription (and over-the-counter) drugs. [read post]